Skip to content
Screener

Mobileye Global Inc. MBLY Mobileye — Research And Development Expense

Other segment segments

All Other Segments
$5M-28.6%

Similar metrics at other companies

Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%
Helios Technologies logo
HLIOUnallocated Expenses — Research And Development Expense
$0
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%
Innoviva, Inc. logo
INVAInternal Expenses — Research And Development Expense
$2.73M+127%

Other financials

Income statement

See full
Revenue$508.0M+0.4%
Gross profit$235.0M-6.7%
Operating income-$30.0M+59.5%
Net income-$21.0M+68.7%
EPS (diluted)-$0.03+62.5%

Balance sheet

See full
Cash & equivalents$1.3B-23.3%
Total debt$62.0M+24.0%
Total equity$8.2B-32.0%
Total assets$8.8B-29.7%

Cash flow

See full
Operating cash flow$135.0M-36.6%
CapEx$21.0M+50.0%
Free cash flow$114.0M-42.7%

Valuation

See full
Market cap$2.13B-81.2%
P/S1.1×-4.8×

Profitability

See full
Gross margin47.4%-1.4pp
Operating margin-207.1%+84.3pp
Net margin-201.5%+90.2pp
FCF margin19.2%-11.4pp

Returns & leverage

See full
Return on equity-40.1%+178pp
Debt / equity0.0×
Current ratio4.6×-2.3×

Where this comes from

Reported directly by Mobileye Global Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Mobileye Global Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-086264
U.S. dollars in millionsMobileyeOtherTotal
Revenues$498$10$508
Cost of revenues1741
Research and development, net1525
Sales and marketing54
General and administrative111
Segment performance$156$(1)$155
Amortization of intangible assets(114)
Share-based compensation(88)

Item 1. Financial Statements (Unaudited)

FAQ

What is Mobileye Global Inc.'s mobileye — research and development expense?
Mobileye Global Inc. (MBLY) reported mobileye — research and development expense of $152M in Q2 2026.
How has Mobileye Global Inc.'s mobileye — research and development expense changed year-over-year?
Mobileye Global Inc.'s mobileye — research and development expense decreased by 29.3% year-over-year, from $215M to $152M.
What is the long-term trend for Mobileye Global Inc.'s mobileye — research and development expense?
Over 3 years (2022 to 2025), Mobileye Global Inc.'s mobileye — research and development expense has grown at a 5.6% compound annual growth rate (CAGR), from $750M to $883M.
What does mobileye — research and development expense mean?
This metric reflects the costs incurred by the segment to develop new technologies, enhance existing products, and innovate within its specific market. For technology-driven segments, this is a critical investment indicator that signals future competitiveness and product pipeline health. High spending in this area often indicates a commitment to maintaining a technological moat.

Ask your AI about Mobileye Global Inc.'s mobileye — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude